- Recent Funding
- Investors
- Kalehua Capital
KKalehua Capital portfolio
Kalehua Capital has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months.
About this page
Its most recent investment on record is Vaderis Therapeutics's $152M Series B+ round in August 2026, alongside EQT Life Sciences, Droia Ventures, TCG Crossover and 4 others. That company is in Health and bio.
What Kalehua Capital invests in
- Health and bio · 1 · 100%
How Kalehua Capital invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $152M |
Kalehua Capital portfolio companies
VVaderis Therapeutics$152MSeries B+ · Aug 2026
| Company | Round with Kalehua Capital | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $152M | $152M | Aug 11, 2026 Series B+ |
Most frequent co-investors
PPerceptive Advisors1 shared round · last Aug 11, 2026
OOmega Funds1 shared round · last Aug 11, 2026
EEQT Life Sciences1 shared round · last Aug 11, 2026
DDroia Ventures1 shared round · last Aug 11, 2026
TTCG Crossover1 shared round · last Aug 11, 2026
MMedicxi1 shared round · last Aug 11, 2026
GGoldman Sachs Alternatives1 shared round · last Aug 11, 2026
Similar investors
IIzou Partners2 companies · 2 deals in 12 mo
- TThe Ljungstrom Family Office2 companies · 2 deals in 12 mo
AAble Partners3 companies · 1 deal in 12 mo
OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
SSide Stage Ventures3 companies
BBdc Thrive venture5 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name Kalehua Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Kalehua Capital, which is a subset of its real portfolio. API: /api/v1/investors/kalehua-capital (get a free API key). More: the most active VC firms and new venture capital funds.